Literature DB >> 10069814

The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains.

J Biernat1, E M Mandelkow.   

Abstract

The differentiation of neurons and the outgrowth of neurites depends on microtubule-associated proteins such as tau protein. To study this process, we have used the model of Sf9 cells, which allows efficient transfection with microtubule-associated proteins (via baculovirus vectors) and observation of the resulting neurite-like extensions. We compared the phosphorylation of tau23 (the embryonic form of human tau) with mutants in which critical phosphorylation sites were deleted by mutating Ser or Thr residues into Ala. One can broadly distinguish two types of sites, the KXGS motifs in the repeats (which regulate the affinity of tau to microtubules) and the SP or TP motifs in the domains flanking the repeats (which contain epitopes for antibodies diagnostic of Alzheimer's disease). Here we report that both types of sites can be phosphorylated by endogenous kinases of Sf9 cells, and that the phosphorylation pattern of the transfected tau is very similar to that of neurons, showing that Sf9 cells can be regarded as an approximate model for the neuronal balance between kinases and phosphatases. We show that mutations in the repeat domain and in the flanking domains have opposite effects. Mutations of KXGS motifs in the repeats (Ser262, 324, and 356) strongly inhibit the outgrowth of cell extensions induced by tau, even though this type of phosphorylation accounts for only a minor fraction of the total phosphate. This argues that the temporary detachment of tau from microtubules (by phosphorylation at KXGS motifs) is a necessary condition for establishing cell polarity at a critical point in space or time. Conversely, the phosphorylation at SP or TP motifs represents the majority of phosphate (>80%); mutations in these motifs cause an increase in cell extensions, indicating that this type of phosphorylation retards the differentiation of the cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069814      PMCID: PMC25198          DOI: 10.1091/mbc.10.3.727

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  75 in total

1.  Phosphorylation of microtubule-associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics.

Authors:  S Illenberger; G Drewes; B Trinczek; J Biernat; H E Meyer; J B Olmsted; E M Mandelkow; E Mandelkow
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

2.  A spatial gradient of tau protein phosphorylation in nascent axons.

Authors:  J W Mandell; G A Banker
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

Review 3.  Tau in Alzheimer's disease.

Authors:  E M Mandelkow; E Mandelkow
Journal:  Trends Cell Biol       Date:  1998-11       Impact factor: 20.808

4.  Juvenile and mature MAP2 isoforms induce distinct patterns of process outgrowth.

Authors:  N Leclerc; P W Baas; C C Garner; K S Kosik
Journal:  Mol Biol Cell       Date:  1996-03       Impact factor: 4.138

5.  Phosphorylation of recombinant tau by cAMP-dependent protein kinase. Identification of phosphorylation sites and effect on microtubule assembly.

Authors:  C W Scott; R C Spreen; J L Herman; F P Chow; M D Davison; J Young; C B Caputo
Journal:  J Biol Chem       Date:  1993-01-15       Impact factor: 5.157

6.  Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

Authors:  G T Bramblett; M Goedert; R Jakes; S E Merrick; J Q Trojanowski; V M Lee
Journal:  Neuron       Date:  1993-06       Impact factor: 17.173

7.  Process formation in Sf9 cells induced by the expression of a microtubule-associated protein 2C-like construct.

Authors:  N LeClerc; K S Kosik; N Cowan; T P Pienkowski; P W Baas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  Taxol-induced flexibility of microtubules and its reversal by MAP-2 and Tau.

Authors:  R B Dye; S P Fink; R C Williams
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

9.  Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons.

Authors:  M A Burack; S Halpain
Journal:  Neuroscience       Date:  1996-05       Impact factor: 3.590

10.  Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease.

Authors:  A Ebneth; R Godemann; K Stamer; S Illenberger; B Trinczek; E Mandelkow
Journal:  J Cell Biol       Date:  1998-11-02       Impact factor: 10.539

View more
  50 in total

1.  Phosphorylation-dependent localization of microtubule-associated protein MAP2c to the actin cytoskeleton.

Authors:  R S Ozer; S Halpain
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

2.  FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease.

Authors:  Waltraud Mair; Jan Muntel; Katharina Tepper; Shaojun Tang; Jacek Biernat; William W Seeley; Kenneth S Kosik; Eckhard Mandelkow; Hanno Steen; Judith A Steen
Journal:  Anal Chem       Date:  2016-03-07       Impact factor: 6.986

3.  Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration.

Authors:  Xiaoyu Li; Yatender Kumar; Hans Zempel; Eva-Maria Mandelkow; Jacek Biernat; Eckhard Mandelkow
Journal:  EMBO J       Date:  2011-10-18       Impact factor: 11.598

4.  PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actin.

Authors:  Dorthe Matenia; Bettina Griesshaber; Xiao-yu Li; Anja Thiessen; Cindy Johne; Jian Jiao; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  Mol Biol Cell       Date:  2005-07-12       Impact factor: 4.138

5.  Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation.

Authors:  Fei Liu; Bin Li; E-Jan Tung; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  Eur J Neurosci       Date:  2007-12-04       Impact factor: 3.386

6.  Microtubule affinity regulating kinase activity in living neurons was examined by a genetically encoded fluorescence resonance energy transfer/fluorescence lifetime imaging-based biosensor: inhibitors with therapeutic potential.

Authors:  Thomas Timm; Jens Peter von Kries; Xiaoyu Li; Hans Zempel; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

Review 7.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

8.  Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model.

Authors:  Meghan N Le; Wonhee Kim; Sangmook Lee; Ann C McKee; Garth F Hall
Journal:  Am J Neurodegener Dis       Date:  2012-11-25

9.  MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1.

Authors:  Thomas Timm; Xiao-Yu Li; Jacek Biernat; Jian Jiao; Eckhard Mandelkow; Joel Vandekerckhove; Eva-Maria Mandelkow
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

Review 10.  Pharmacophore-based models for therapeutic drugs against phosphorylated tau in Alzheimer's disease.

Authors:  Jangampalli Adi Pradeepkiran; Arubala P Reddy; P Hemachandra Reddy
Journal:  Drug Discov Today       Date:  2018-11-16       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.